Abstract
A recent study by Gressner and colleagues suggested caffeine may block CCN2 expression in hepatic cells. This commentary briefly summarizes these observations.
Similar content being viewed by others
References
Gressner OA, Lahme B, Rehbein K, Siluschek M, Weiskirchen R, Gressner AM (2008). Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. J Hepatol (in press)
Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, Leask A (2001) CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 276:10594–10601 doi:10.1074/jbc.M010149200
Leask A, Abraham DJ (2004) The control of TGFβ signaling in wound healing and fibrosis. FASEB J 18:816–827 doi:10.1096/fj.03-1273rev
Ruhl CE, Everhart JE (2005) Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 129:1928–1936 doi:10.1053/j.gastro.2005.08.056
Author information
Authors and Affiliations
Corresponding author
Additional information
This commentary also appears online under Newsletter section of the ICCNS Website at http://ccnsociety.com.
Rights and permissions
About this article
Cite this article
Leask, A. The Starbuck stops here: it’s a Smad world. J. Cell Commun. Signal. 2, 1–2 (2008). https://doi.org/10.1007/s12079-008-0025-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12079-008-0025-3